Teligent Inc. is a Teligent Inc is a specialty generic pharmaceutical company.
Teligent Inc. (TLGT) had a good day on the market for Friday March 05 as shares jumped 8.55% to close at $0.80. About 3.26 million shares traded hands on 5,325 trades for the day, compared with an average daily volume of n/a shares out of a total float of 67.49 million. After opening the trading day at $0.75, shares of Teligent Inc. stayed within a range of $0.81 to $0.68.
With today’s gains, Teligent Inc. now has a market cap of $54.22 million. Shares of Teligent Inc. have been trading within a range of $6.46 and $0.46 over the last year, and it had a 50-day SMA of $n/a and a 200-day SMA of $n/a.
Teligent Inc is a specialty generic pharmaceutical company. Teligent develops, manufactures, and sells (under its own label) topical, injectable, complex, and ophthalmic pharmaceutical products in the U.S. and Canada. The product portfolio consists of hospital-based sterile injectable products and topical products (creams like Synalar and Spectazole; lotions like Kenalog; ointments like Topicort and Kenalog; and topical solutions like Pennsaid and Xylocaine). The company also offers services to the pharmaceutical, over-the-counter, and cosmetic markets.
Teligent Inc. is based out of Buena, NJ and has some 252 employees. Its CEO is Timothy B. Sawyer.